Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiomyopathy
Biotech
Edgewise unveils promising early data for heart disease drug
Edgewise tested its drug, dubbed EDG-7500, separately in healthy subjects and in patients with obstructive HCM.
Zoey Becker
Sep 20, 2024 4:00am
BioMarin halts preclinical gene therapy for heart condition
Aug 6, 2024 9:01am
Bayer pays $310M for Europe rights to BridgeBio's Vyndaqel rival
Mar 4, 2024 8:22am
Cytokinetics not in sale process, CEO says
Feb 28, 2024 11:25am
AstraZeneca's heart disease trial hits, teeing up Pfizer clash
Feb 2, 2024 6:43am
Novartis backs out of Cytokinetics deal: reports
Jan 12, 2024 5:26am
